Literature DB >> 14287992

CLINICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.

R L HERTING, F LOPEZ, E SCHERFLING, J C SYLVESTER, R WIEGAND.   

Abstract

Entities:  

Keywords:  BLOOD; METABOLISM; SULFONAMIDES; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14287992

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  2 in total

Review 1.  Pharmacokinetic considerations in rational drug design.

Authors:  M Gumbleton; W Sneader
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

2.  Kelfiprim, a new sulpha-trimethoprim combination, versus cotrimoxazole, in the treatment of urinary tract infections: a multicentre, double-blind trial.

Authors:  E Pisani; M Pavone-Macaluso; F Rocco; F Piaia; F Pirozzi; U Rotolo; M Lamartina; D Melloni; P Larcker
Journal:  Urol Res       Date:  1982-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.